{"id":10781,"date":"2025-06-03T08:53:41","date_gmt":"2025-06-03T08:53:41","guid":{"rendered":"https:\/\/catsci.com\/?p=10781"},"modified":"2025-10-21T13:56:38","modified_gmt":"2025-10-21T13:56:38","slug":"bioscience-service-for-early-drug-discovery","status":"publish","type":"post","link":"https:\/\/catsci.com\/news\/bioscience-service-for-early-drug-discovery\/","title":{"rendered":"CatSci Unveils State-of-the-Art Bioscience Service to Accelerate Early-Stage Drug Discovery"},"content":{"rendered":"\n

CatSci Ltd are thrilled to announce the launch of our new Bioscience service<\/a>, expanding the company\u2019s integrated drug discovery offering with bioscience capabilities that add in vitro and cellular insight to complement our chemistry expertise.\u00a0<\/p>\n\n\n\n

Housed in a purpose-built laboratory at BioCity Nottingham<\/a>, the platform combines high-end instrumentation with a multidisciplinary team of expert scientists to deliver rapid, decision-ready data for biotechs and pharma companies worldwide.\u00a0<\/p>\n\n\n\n

\n
\n

\u201cGreat compounds often fail to deliver early promise \u2013 not because the idea is wrong, but because the complex biology is not fully understood in time. <\/em> <\/p>\n\n\n\n

The right assays \u2013 and the right people \u2013 make all the difference.\u201d\u00a0 <\/em><\/p>\n\n\n\n

Kathy Dodgson, Technical Director of Bioscience.\u00a0<\/em>\u00a0<\/p>\n<\/blockquote>\n<\/blockquote>\n\n\n

\n
\"\"<\/figure>\n<\/div>\n\n\n

What CatSci’s Bioscience Service Offers<\/strong><\/h4>\n\n\n\n
Discovery Stage<\/strong><\/th>Bioscience Services <\/strong><\/th><\/tr><\/thead>
Target Discovery & Validation<\/td>Proof of Concept (PoC) and Mode of Action studies (MoA) to validate initial hypothesis and ensure a target is “druggable” through modulation<\/td><\/tr>
Hit Finding<\/td>Fragment & small molecule screening, orthogonal confirmation; identifying promising hit series for development into lead compounds<\/td><\/tr>
Hit-To-Lead<\/td>Structure-activity-relationship (SAR) elucidation, cytotoxicity & functional profiling <\/td><\/tr>
Lead Optimisation<\/td>Examinations of a smaller number of lead compounds across more complex assay systems to optimise properties: efficacy, selectivity, solubility, toxicity, etc. <\/td><\/tr>
Preclinical Support <\/td>Ex vivo<\/em> sample analysis (e.g. animal tissue or human whole blood samples), multiparametric readouts in complex models, and testing for side effects (different cell lines or species). <\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

Bioscience Technology Highlights <\/strong><\/h4>\n\n\n\n